Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact.
Jennifer Ohn, MPH
Advertisement
Articles by Jennifer Ohn, MPH
Advertisement
Latest Updated Articles
- Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy
Published: May 13th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
